Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Lutonix Inc.

Division of Becton Dickinson & Co.

Latest From Lutonix Inc.

Device Exec Pleads Guilty To Trade Secret Theft

Christopher Barry, a former VP of R&D at Bard subsidiary Lutonix, pleaded guilty to one count of theft of trade secrets. He now faces up to two and a half years in prison.

Legal Issues Intellectual Property

FDA Panel Date Set For Bard’s Lutonix Drug-Coated Balloon

The agency’s Circulatory System Devices Panel will meet June 12 to consider Bard’s PMA, supported by data from Levant 2, a 476-patient randomized non-inferiority trial comparing Lutonix to a standard peripheral balloon catheter for the treatment of stenosis of the femoropopliteal arteries.

Medical Device

Bard’s Lutonix Drug-Coated Balloon Shows Efficacy In Early Trial Results

Six-month data from the rigorous Levant 2 trial, presented at the TCT conference in San Francisco, show peripheral angioplasty with Bard’s Lutonix paclitaxel-coated balloon reduces restenosis compared with regular balloon angioplasty. The findings give the company an edge in the race to be the first on the U.S. market with a drug-coated peripheral angioplasty balloon.

Medical Device Clinical Trials

New CoreValve Data Featured In TCT Late-Breaking Clinical Trials

Data on Medtronic’s CoreValve transcatheter aortic valve replacement device will headline this year’s Transcatheter Cardiovascular Therapeutics conference, joined by data on biodegradable drug-eluting stents, as well as drug-coated balloon results, in the late-breaking trial sessions.

Clinical Trials
See All

Company Information

  • Industry
  • Medical Devices
    • Implantable Devices
    • Surgical Equipment & Devices
      • Minimally or Less Invasive
  • Pharmaceuticals
  • Therapeutic Areas
  • Cardiovascular
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Becton Dickinson & Co.
  • Senior Management
  • Chris Barry, VP, R&D
    Leslie Trigg, EVP, Mktg. & Commercialization Strategy
  • Contact Info
  • Lutonix Inc.
    Phone: (763) 445-2352
    7351 Kirkwood Ln. N.
    Ste. 138
    Maple Grove, MN 55369